Positron Corporation, a Cardiac Molecular Imaging Company, announced today their jointly developed Attrius™ Cardiac Positron Emission Tomography (PET) scanner was featured in an article on the largest community Web site for medical imaging professionals, AuntMinnie.com.
Joseph Oliverio, President of Positron states that, "We are pleased that such a well respected medical news service reinforces the significance of Positron’s reintroduction of a dedicated PET only device focused on cardiology use.” Oliverio also stated, “Our AttriusTM system has been developed specifically for cardiologists looking to provide patients with a more accurate diagnosis of coronary disease while at the same time providing a cost savings and efficiencies to our healthcare system. We anticipate significant demand for our product and see the introduction of the AttriusTM as the launching pad for a widespread industry use of Cardiac PET. The size of the market is significant with clinical and economic benefits to patients, healthcare providers and insurers. Positron will use this opportunity to introduce its PosiRx solution that will provide physicians a total solution for their businesses and flexible alternatives to traditional financing options.”
About Positron
Positron Corporation is a vertically integrated company in the field of Cardiac Nuclear Medicine. The Company operates through two segments: Radiopharmaceutical Products and Molecular Imaging Devices. The Pharmaceutical Products segment offers world’s first robotic systems (Nuclear Pharm-Assis® & Cardio-Assist™) for distribution and delivery of radiopharmaceuticals used for the diagnosis of cardiac disease; the Molecular Imaging Devices segment provides PET scanners (Attrius™) and SPECT cameras (Pulse®). Positron’s SPECT and PET cardiac molecular imaging systems and radiopharmaceutical deliver devices are installed in more than 150 hospitals and physician offices around the world.
Contact:
Positron Corporation
Joseph Oliverio, President
(716) 870-5924
source: yahoo
Joseph Oliverio, President of Positron states that, "We are pleased that such a well respected medical news service reinforces the significance of Positron’s reintroduction of a dedicated PET only device focused on cardiology use.” Oliverio also stated, “Our AttriusTM system has been developed specifically for cardiologists looking to provide patients with a more accurate diagnosis of coronary disease while at the same time providing a cost savings and efficiencies to our healthcare system. We anticipate significant demand for our product and see the introduction of the AttriusTM as the launching pad for a widespread industry use of Cardiac PET. The size of the market is significant with clinical and economic benefits to patients, healthcare providers and insurers. Positron will use this opportunity to introduce its PosiRx solution that will provide physicians a total solution for their businesses and flexible alternatives to traditional financing options.”
About Positron
Positron Corporation is a vertically integrated company in the field of Cardiac Nuclear Medicine. The Company operates through two segments: Radiopharmaceutical Products and Molecular Imaging Devices. The Pharmaceutical Products segment offers world’s first robotic systems (Nuclear Pharm-Assis® & Cardio-Assist™) for distribution and delivery of radiopharmaceuticals used for the diagnosis of cardiac disease; the Molecular Imaging Devices segment provides PET scanners (Attrius™) and SPECT cameras (Pulse®). Positron’s SPECT and PET cardiac molecular imaging systems and radiopharmaceutical deliver devices are installed in more than 150 hospitals and physician offices around the world.
Contact:
Positron Corporation
Joseph Oliverio, President
(716) 870-5924
source: yahoo
0 comments:
Post a Comment